Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
The Strait of Hormuz Isn’t Just an Oil Problem, It’s Now a Food Problem - 2Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 3NASA probe captures stunning photos of Earth and moon on the way to infamous asteroid Apophis
- 4Home Mechanization Frameworks for Brilliant Residing
- 5Full Supreme Court to hear challenge to Judicial Selection Committee law
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- Pocket-Accommodating Jeep Wrangler Buying Guide for Seniors
- Overhaul Your Rest: Tips for a Serene Evening
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- 2026 Golden Globes live updates: Red carpet arrivals will kick off the night; Nikki Glaser set to host
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- The most effective method to Guarantee Simple Availability in Seniors' SUVs
- Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
